About

IDT Biologika is a global contract development and manufacturing organization for vaccines, cell & gene therapeutics, and fill-finish of other biologics. This includes end-to-end services from process development through drug substance manufacturing up to BSL-2, sterile liquid dosage filling & lyophilization, labeling & packaging to quality control & analytics. We offer clients in B2B business a single source CDMO partner at our sites in the USA and Germany, with seamless end-to-end solutions and the ability to nimbly scale projects from development through to commercialization. IDT Biologika handles every step in manufacturing and packaging of small clinical batches and large-scale commercial products. Our fully integrated services are underscored by our commitment to quality and operational excellence that flows through our best-in-class process and cGMP manufacturing capabilities meeting FDA, EMA and ANVISA standards. If you chose IDT Biologika, you receive reliable high quality services on products because we have the quality and supply mindset underlining the customer needs for speed to market. We supply our client’s products in vials, pre-filled syringes, autoinjectors or as combination products. IDT Biologika is unique in its ability to accommodate the development, testing and manufacture of products for the world’s leading biopharmaceutical companies. Many human vaccines developed by IDT Biologika, together with international partners, are already in use, fighting infectious diseases such as COVID-19, tuberculosis, AIDS, malaria, dengue, ebola and chikungunya. For more information see www.idt-biologika.com. About IDT Biologika IDT Biologika is a leading CDMO providing end-to-end services in development and manufacturing of Viral Vaccines, CGT products and aseptic fill-finish for other Biologics and Sterile Injectables. We have GMP sites located in Germany and Maryland, US for clinical and commercial manufacturing. Our excellent track record is manifested by successful inspections and approvals from major regulatory agencies including FDA, EMA and ANVISA and by delivering for commercial programs for over three decades. About IDT Biologika GmbH IDT Biologika is a leading CDMO providing end-to-end services in development and manufacturing of Viral Vaccines, CGT products and aseptic fill-finish for other Biologics and Sterile Injectables. We have GMP sites located in Germany and Maryland, US for clinical and commercial manufacturing. Our excellent track record is manifested by successful inspections and approvals from major regulatory agencies including FDA, EMA and ANVISA and by delivering for commercial programs for over three decades. IDT Biologika is a global CDMO specializing in biologics, biosimilars and sterile injectables, including vaccines and gene and immune therapeutics. With decades of experience across various manufacturing platforms, we combine cutting-edge innovations in advanced therapies, our manufacturing expertise and our skilled team to deliver customized solutions to our customers. Our end-to-end services include process development, drug substance manufacturing, sterile dosage filling, labeling, packaging and quality control. All analytical services are performed in-house. From early-stage development to clinical and commercial manufacturing, we ensure seamless integration at every step, delivering flexibility, regulatory compliance, and the highest quality standards. Our commitment to operational excellence is reflected in our best-in-class process and GMP manufacturing, meeting FDA, EMA and ANVISA standards. Driven by passion, innovation, and a commitment to excellence, we strive to make a meaningful impact on global healthcare by helping our customers bring their products to market. www.idt-biologika.com